ReWalk robotic exoskeleton clears FDA

[grow_thumb image=”” thumb_width=”130″ /]Finally one of the several exoskeletons under development to aid paraplegics to walk has gained FDA approval for its ‘personal’ version for use at home. The Argo ReWalk [TTA 21 Nov 13 and 2011 coverage] enables mobility for many paraplegics and mimics natural gait through wearable brace supports, motion sensors and a computer-based control system. Crutches are used for additional stability. It also has a rehabilitation version for clinical settings. The importance of mobility, even if limited, cannot be exaggerated. Wheelchair-only mobility can lead to muscle deterioration, blood clots and heart conditions. As part of the de novo clearance, ReWalk will be doing a post-market study for FDA to determine adverse events. One of the early adopters is Captain Derek Herrera, who works for the Marine Special Operations Command and whose unit is being donated by the MARSOC Foundation.  ReWalk release and website. Medgadget, MedCityNews, NBC.